Outcome of patients with sarcoidosis refractory to TNF antagonists: a case series

Background: Tumor necrosis factor (TNF) antagonists have been reported as an efficient third-line therapy for sarcoidosis but there is no data regarding patients who do not respond to this treatment. Objective: To report the characteristics, the outcome and the response to therapy of patients with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Thery-Casari, Clémence, Jamilloux, Yvan, Bouvry, Diane, Chapelon-Abric, Catherine, Marquet, Alicia, Bielefeld, Philip, Schleinitz, Nicolas, Vukusic, Sandra, Girszyn, Nicolas, Fain, Olivier, Bonnet, Fabrice, Valeyre, Dominique, Seve, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170127/
https://www.ncbi.nlm.nih.gov/pubmed/32476925
http://dx.doi.org/10.36141/svdld.v35i4.6999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170127/
https://www.ncbi.nlm.nih.gov/pubmed/32476925
http://dx.doi.org/10.36141/svdld.v35i4.6999

Ejemplares similares